OKERA ENABLES FORTUNE 500 PHARMACEUTICAL COMPANY TO PROTECT PATIENTS’ DATA DURING DRUG DISCOVERY Executive Summary This Fortune 500 Company is a global biopharmaceutical company with a mission to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. The company deployed Okera’s Active Data Access Platform (ODAP) to replace manual access control in its Amazon S3 data lake. In the process, it was able to reap the following benefits. OKERA BENEFITS • Secure and segregated access to patients’ data from clinical drug trials • Dynamic obfuscation to protect sensitive data and comply with regulatory requirements such as GDPR, CCPA, and HIPAA • Streamlined access control for multi-data source, multi-tool environment • Flexibility to

Join for free to read